FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, namely to transplantation of autologous haemopoietic stem cells of peripheral blood. Method involves preparation and storage of autologous haemopoietic peripheral blood stem cells in the form of a leucolayer suspended in a multicomponent anticoagulant solution, with no air access at (+3)–(+ 5) °C for 3–6 days with subsequent reinfusion.
EFFECT: invention allows excluding cell freezing during storage.
1 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF STORAGE OF NON-CRYOPRESERVED AUTOLOGOUS HEMATOPOIETIC STEM CELLS FROM PERIPHERAL BLOOD | 2022 |
|
RU2799019C1 |
| METHOD FOR PREDICTION OF EARLY RECURRENCE IN PATIENTS WITH CLASSICAL HODGKIN'S LYMPHOMA | 2019 |
|
RU2702360C1 |
| AUTOLOGIC HEMOPOIETIC STEM CELLS PREPARATION AND METHOD FOR PRODUCING, CRYOGENIC PRESERVING AND APPLYING IT IN TREATING TRAUMATIC NERVOUS SYSTEM DISEASE CASES | 2005 |
|
RU2283119C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME FROM PNEUMONIA IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES AFTER HIGH-DOSAGE POLYCHEMOTHERAPY WITH TRANSPLANTATION OF AUTOLOGICAL HEMATOPOIETIC STEM CELLS | 2021 |
|
RU2770268C1 |
| COMBINATION CRYOPROTECTOR "DIMETHYL SULPHOXIDE/RHEOPOLYGLUCIN" FOR STEM CELL CRYOPRESERVATION AND METHOD FOR CRYOPRESERVATION THEREOF FOR CLINICAL APPLICATIONS | 2014 |
|
RU2563117C1 |
| METHOD FOR PREDICTING DISEASE-FREE SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | 2015 |
|
RU2580648C1 |
| METHOD FOR PREDICTION OF HEMATOPOIETIC STEM CELL COLLECTION EFFICIENCY | 2023 |
|
RU2821227C1 |
| BIOMEDICAL CELL PREPARATION | 2017 |
|
RU2647429C1 |
| METHOD FOR UNRESTRICTED FREEZING PERIPHERAL BLOOD PRECURSOR CELLS AT MINUS 80 °C UNDER PROTECTION OF DIMETHYLSULPHOXID | 2018 |
|
RU2707921C1 |
| METHOD OF CRYOPRESERVATION OF HEMATOPOIETIC STEM CELLS OF UMBILICAL BLOOD | 2009 |
|
RU2416197C1 |
